Cosmo, Glenmark secure UK MHRA approval of Winlevi for treatment of acne


Scientists loading machinery in lab

ER Productions Limited/DigitalVision via Getty Images

Cosmo Pharmaceuticals N.V. (OTCPK:CMOPF) Monday said that Glenmark had received approval from the Medicines and Healthcare products Regulatory Agency (MHRA) to market Winlevi in the United Kingdom.

Winlevi is the first topical acne treatment in nearly 40 years with a



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Back To Top